The performance of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the expiry in key markets has introduced considerable uncertainty . Investors are now facing the impact of rival medications